Servier, founded in 1954, is the first French independent pharmaceutical group. We are present in 140 countries, with more than 21 000 employees, including close to 3000 in R&D.
Patients with Advanced Metastatic Colorectal Cancer in Europe Now Have a New Treatment Option as LONSURF® (trifluridine/tipiracil) Receives EU Approval
ISHR-ES – Servier Research Fellowship 2016 awarded to Dr Hector Cabrera-Fuentes
> All News
© 2016 SERVIER HONG KONG LIMITED, an incorporated company of Servier. All Rights Reserved. Report a side-effect with a drug.